XXII - 22nd Century Group, Inc.
| Previous Close | 0.8951 |
| Open | 0.8951 |
| Bid | 0.8960 x 1000 |
| Ask | 0.9500 x 1300 |
| Day's Range | 0.8888 - 0.9600 |
| 52 Week Range | 0.7000 - 2.8800 |
| Volume | 972,070 |
| Avg. Volume | 1,395,146 |
| Market Cap | 127M |
| Beta (5Y Monthly) | 1.28 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.2350 |
| Earnings Date | Nov 8, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.50 |
- GlobeNewswire
22nd Century Group Announces Management Changes
Williamsville, NY, Dec. 13, 2019 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content (VLNC) tobacco and hemp/cannabis plant research, announced today changes to the Company’s management. “Over the past few months we have made rapid and significant progress in strengthening 22nd Century Group as we execute against our two growth strategies,” commented James W. Cornell, Director & Chairman of the Board of 22nd Century Group.
- Benzinga
22nd Century Enters CBD Space With $24M Investment In Panacea
Investments are anticipated to total $24 million, in a combination of cash and 22nd Century stock. “Our objective is to build a leading, profitable business in the fast-growing, emerging, legal hemp/cannabis space, and Panacea is a rapidly-growing, vertically-integrated, consumer-facing business with a very strong management team," Cliff Fleet, President and CEO of 22nd Century Group said in a statement.
- Business Wire
Shareholder Alert: Robbins LLP Reminds Investors 22nd Century Group, Inc. (XXII) Sued for Misleading Shareholders
Shareholder rights law firm Robbins LLP reminds investors that purchasers of 22nd Century Group, Inc. filed a class action complaint against the company for alleged violations of the Securities and Exchange Act of 1934 between February 18, 2016 and July 31, 2019.
- GlobeNewswire
22nd Century Group Enters CBD Health and Wellness Market with Investment in Panacea Life Sciences, Inc.
Williamsville, NY, Dec. 03, 2019 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content (VLNC) tobacco and hemp/cannabis plant research, announced today the initial closing of an investment in Panacea Life Sciences, Inc. (Panacea), a rapidly-growing, vertically-integrated, consumer-facing company operating exclusively in the legal, hemp-derived, CBD product space. 22nd Century’s investments in Panacea over the next twelve to eighteen months are expected to total $24 million, in a combination of cash and 22nd Century stock in exchange for Panacea-issued debt and preferred equity.
- Thomson Reuters StreetEvents
Edited Transcript of XXII earnings conference call or presentation 8-Nov-19 2:00pm GMT
Q3 2019 22nd Century Group Inc Earnings Call
- GlobeNewswire
22nd Century Group Comments on Delay of Reduced Nicotine Rule for Cigarettes
Williamsville, NY, Nov. 21, 2019 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content (VLNC) tobacco and hemp/cannabis research, responded today to the FDA’s recent removal of the Tobacco Product Standard for Nicotine Level of Certain Tobacco Products from the Trump administration’s ‘unified agenda.’ The much anticipated Notice of Proposed Rulemaking (NPRM) for the reduced nicotine product standard, which was expected in October, was listed as being “Withdrawn” as of October 23, 2019, on the White House Office of Information and Regulatory Affairs website. The unified agenda was updated with the new information on Wednesday, November 20, 2019, as part of a semiannual review.
- Business Wire
22nd Century Group Files 2019 Third Quarter Report
22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content (VLNC) tobacco and hemp/cannabis research, announced today that the Company filed its Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 with the U.S. Securities and Exchange Commission. As previously announced, the Company will provide a business update for investors on an audio only webcast to be held on Friday, November 8, 2019, at 9:00 AM Eastern time. Clifford B. Fleet, President and Chief Executive Officer of 22nd Century Group, together with John Brodfuehrer, Chief Financial Officer, will conduct the webcast.
- GlobeNewswire
22nd Century Group Announces Webcast to Provide Business Update
WILLIAMSVILLE, NY -- 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content (VLNC) tobacco, and hemp/cannabis plant research, announced today that the Company will provide a business update for investors via an audio-only webcast on Friday, November 8, 2019, at 9:00 AM Eastern time. Cliff Fleet, Chief Executive Officer of 22nd Century Group, together with John Brodfuehrer, Chief Financial Officer, will conduct the webcast. Interested parties are invited to listen to the live event on the 22nd Century website: www.xxiicentury.com/media/2019Q3BusinessUpdate.
- Simply Wall St.
Does 22nd Century Group (NYSEMKT:XXII) Have A Healthy Balance Sheet?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
- Zacks
Trump May Ban Flavored E-Cigarettes: Who Wins, Who Loses
Vaping is a growing trend among youngsters, but Trump's recent threat to ban flavored e-cigarettes raises questions. Will traditional cigarette get back its lost glory?
- Motley Fool
3 Pot Stocks to Avoid Like the Plague in September
These marijuana stocks are unlikely to have investors seeing green in the near term.
- Motley Fool
Only These 10 Pot Stocks Ended August Higher
Despite another miserable month for marijuana stocks, these companies managed to buck the trend.
- Motley Fool
3 Best Marijuana Stocks of August -- Are They Buys Now?
Most pot stocks performed poorly last month, but not these three highfliers.
- GuruFocus.com
22nd Century Group Inc (XXII) President and CEO Clifford B Fleet Bought $190,000 of Shares
President and CEO of 22nd Century Group Inc (30-Year Financial, Insider Trades) Clifford B Fleet (insider trades) bought 100,000 shares of XXII on 08/27/2019 at an average price of $1.9 a share. Continue reading...
- Zacks
Will 22nd Century Group Continue to Surge Higher?
As of late, it has definitely been a great time to be an investor 22nd Century Group.
- Simply Wall St.
22nd Century Group, Inc. (NYSEMKT:XXII): What Does Its Beta Value Mean For Your Portfolio?
If you're interested in 22nd Century Group, Inc. (NYSEMKT:XXII), then you might want to consider its beta (a measure...
- Thomson Reuters StreetEvents
Edited Transcript of XXII earnings conference call or presentation 8-Aug-19 8:00pm GMT
Q2 2019 22nd Century Group Inc Earnings Call
Motley Fool22nd Century Group Inc (XXII) Q2 2019 Earnings Call Transcript
XXII earnings call for the period ending June 30, 2019.
- ACCESSWIRE
The LD Micro Index Turns Four Years Old
LOS ANGELES, CA / ACCESSWIRE / August 1, 2019 / LD Micro is pleased to announce that the LD Micro Index is being reconstituted (again) as of August 1, 2019. LD Micro has always held the belief that our ...
- Simply Wall St.
22nd Century Group, Inc. (NYSEMKT:XXII) Insiders Have Been Selling
We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are...
- Motley Fool
The 9 Biggest Tobacco Stocks
There aren't a huge number of U.S.-listed stocks with a tobacco focus, but these companies still combine to be a force in the global industry.
